National Society to Prevent Blindness,
 Vision Problems in the US: Data Analysis. New York, NY National Society to Prevent Blindness1980;1- 46
Klein
 R, Wang
 Q, Klein
 BEK, Moss
 SE, Meuer
 SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci. 1995;36182- 191
Klein
 R, Klein
 BEK, Lee
 KE. Changes in visual acuity in a population: the Beaver Dam Eye Study. Ophthalmology. 1996;1031169- 1178
Attebo
 K, Mitchell
 P, Smith
 W. Visual acuity and the causes of visual loss in Australia: the Blue Mountains Eye Study. Ophthalmology. 1996;103357- 364
Gregor
 Z, Joffe
 L. Senile macular changes in the black African. Br J Ophthalmol. 1973;62547- 550
Schatz
 H. The senile maculopathies and the retinal pigment epithelium. Int Ophthalmol Clin. 1975;15169- 197
Chumbley
 LC. Impressions of eye diseases among Rhodesian blacks in Mashonaland. S Afr Med J. 1977;52316- 318
Klein
 BEK, Klein
 R. Cataracts and macular degeneration in older Americans. Arch Ophthalmol. 1982;100571- 573
Klein
 R, Rowland
 ML, Harris
 MI. Racial/ethnic differences in age-related maculopathy: third National Health and Nutrition Examination Survey. Ophthalmology. 1995;102371- 381
Schachat
 AP, Hyman
 L, Leske
 MC, Connell
 AMS, Wu
 S-Y.for the Barbados Eye Study Group,
 Features of age-related macular degeneration in a black population. Arch Ophthalmol. 1995;113728- 735
Sommer
 A, Tielsch
 JM, Katz
 J.
 et al.  Racial differences in the cause-specific prevalence of blindness in East Baltimore. N Engl J Med. 1991;3251412- 1417
Green
 WR, Enger
 C. Age-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman Lecture. Ophthalmology. 1993;1001519- 1535
Jampol
 LM, Tielsch
 J. Race, macular degeneration, and the Macular Photocoagulation Study [editorial]. Arch Ophthalmol. 1992;1101699- 1700
The ARIC Investigators,
 The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129687- 702
Jackson
 R, Chambless
 LE, Yang
 K.
 et al.  Differences between respondents and nonrespondents in a multi-center community-based study vary by gender and ethnicity. J Clin Epidemiol. 1996;491441- 1446
Atherosclerosis Risk in Communities (ARIC) Study Research Group,
 ARIC Retinal Photography Protocol, Manual 14A. Chapel Hill, NC ARIC Coordinating Center, School of Public Health, University of North Carolina1996;
Atherosclerosis Risk in Communities (ARIC) Study Research Group,
 ARIC Retinal Reading Center Protocol, Manual 14B. Chapel Hill, NC ARIC Coordinating Center, School of Public Health, University of North Carolina1996;
National Heart, Lung, and Blood Institute,
 Atherosclerosis Risk in Communities Study: Operations Manual No. 2, Cohort Component Procedures, Version 2.0. Chapel Hill, NC ARIC Coordinating Center, School of Public Health, University of North Carolina1988;
Hubbard
 LD, Brothers
 RJ, King
 WN.
 et al.  Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities (ARIC) Study. Ophthalmology. In press.
Sharrett
 AR, Hubbard
 LD, Cooper
 LS.
 et al.  Retinal arteriolar diameters and elevated blood pressure: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. In press.
Klein
 R, Davis
 MD, Magli
 YL, Klein
 BEK. Wisconsin Age-Related Maculopathy Grading System. Madison, Wis Dept of Ophthalmology and Visual Sciences, University of Wisconsin Medical School1991;
Klein
 R, Davis
 MD, Magli
 YL, Segal
 P, Klein
 BE, Hubbard
 L. The Wisconsin Age-Related Maculopathy Grading System. Ophthalmology. 1991;981128- 1134
Burke
 GL, Evans
 GW, Riley
 WA.
 et al.  Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Stroke. 1995;26386- 391
Demirovic
 J, Nabulsi
 A, Folsom
 AR.
 et al.  Alcohol consumption and ultrasonographically assessed carotid artery wall thickness and distensibility: the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation. 1993;882787- 2793
Eckfeldt
 JH, Chambless
 LE, Shen
 YL. Short-term, within-person variability in clinical chemistry test results: experience from the Atherosclerosis Risk in Communities Study. Arch Pathol Lab Med. 1994;118496- 500
Folsom
 AR, Eckfeldt
 JH, Weitzman
 S.
 et al.  Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity: Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke. 1994;2566- 73
Heiss
 G, Sharrett
 AR, Barnes
 R.
 et al.  Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol. 1991;134250- 256
Howard
 G, Burke
 GL, Szklo
 M.
 et al.  Active and passive smoking are associated with increased carotid wall thickness: the Atherosclerosis Risk in Communities Study. Arch Intern Med. 1994;1541277- 1282
Li
 R, Duncan
 BB, Metcalf
 PA.
 et al.  B-mode–detected carotid artery plaque in a general population: Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke. 1994;252377- 2383
Liao
 D, Cooper
 L, Cai
 J.
 et al.  The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology. 1997;16149- 162
Nieto
 FJ, Szklo
 M, Folsom
 AR, Rock
 R, Mercuri
 M. Leukocyte count correlates in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 1992;136525- 537
Perneger
 TV, Nieto
 FJ, Whelton
 PK, Klag
 MJ, Comstock
 GW, Szklo
 M. A prospective study of blood pressure and serum creatinine: results from the "Clue" Study and the ARIC Study. JAMA. 1993;269488- 493
Sharrett
 AR, Patsch
 W, Sorlie
 PD.
 et al.  Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb. 1994;141098- 1104
Landis
 JR, Koch
 GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33159- 174
Hastings
 RP.ed SUGI Supplemental Library User's Guide, Volumes 1 and 2, Version 6. Cary, NC SAS Institute Inc1990;
Vingerling
 JR, Klaver
 CC, Hofman
 A, de Jong
 PT. Epidemiology of age-related maculopathy. Epidemiol Rev. 1995;17347- 360
Klein
 R,  The epidemiology of age-related maculopathy. Fine
 S, Berger
 J, Maguire
 M.eds.Age-Related Macular Degeneration St Louis, Mo CV Mosby Co1999;31- 55
Bischoff
 PM, Flower
 RW. High blood pressure in choroidal arteries as a possible pathogenetic mechanism in senile macular degeneration. Am J Ophthalmol. 1983;96398- 399
Moore
 DJ, Hussain
 AA, Marshall
 J. Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci. 1995;361290- 1297
Klein
 R, Klein
 BEK, Franke
 T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1993;100406- 414
Smith
 W, Mitchell
 P, Leeder
 SR, Wang
 JJ. Plasma fibrinogen, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol. 1998;116583- 587
Klein
 R, Klein
 BEK, Jensen
 SC. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997;1041804- 1812
Cruickshanks
 KJ, Hamman
 RF, Klein
 R, Nondahl
 DM, Shetterly
 SM. The prevalence of age-related maculopathy by geographic region and ethnicity: the Colorado-Wisconsin Study of Age-Related Maculopathy. Arch Ophthalmol. 1997;115242- 250
Vingerling
 JR, Dielemans
 I, Bots
 ML, Hofman
 A, Grobbee
 DE, de Jong
 PT. Age-related macular degeneration is associated with atherosclerosis: the Rotterdam Study. Am J Epidemiol. 1995;142404- 409
Hyman
 LG, Lilienfeld
 AM, Ferris
 FL
 III, Fine
 SL. Senile macular degeneration: a case-control study. Am J Epidemiol. 1983;118213- 227
Silvestri
 G, Johnston
 PB, Hughes
 AE. Is genetic predisposition an important risk factor in age-related macular degeneration? Eye. 1994;8565- 568
Heiba
 IM, Elston
 RC, Klein
 BEK, Klein
 R. Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study. Genet Epidemiol. 1994;1151- 67
Seddon
 JM, Ajani
 UA, Mitchell
 BD. Familial aggregation of age-related maculopathy. Am J Ophthalmol. 1997;123199- 206
Taylor
 HR, West
 S, Munoz
 B, Rosenthal
 FS, Bressler
 SB, Bressler
 NM. The long-term effects of visible light on the eye. Arch Ophthalmol. 1992;11099- 104
Cruickshanks
 KJ, Klein
 R, Klein
 BEK. Sunlight and age-related macular degeneration: the Beaver Dam Eye Study. Arch Ophthalmol. 1993;111514- 518
Klein
 R, Klein
 BEK, Linton
 KLP. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1992;99933- 943
Klein
 R, Meuer
 SM, Moss
 SE, Klein
 BEK. Detection of drusen and early signs of age-related maculopathy using a nonmydriatic camera and a standard fundus camera. Ophthalmology. 1992;991686- 1692
Mitchell
 P, Smith
 W, Attebo
 K, Wang
 JJ. Prevalence of age-related maculopathy in Australia: the Blue Mountains Eye Study. Ophthalmology. 1995;1021450- 1460
Vingerling
 JR, Dielemans
 I, Hofman
 A.
 et al.  The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995;102205- 210
West
 SK, Muñoz
 B, Schein
 OD, Duncan
 DD, Rubin
 GS. Racial differences in lens opacities: the Salisbury Eye Evaluation (SEE) project. Am J Epidemiol. 1998;1481033- 1039